Today: January 21, 2017, 11:36 am
  
Business

Award-Winning PHT Corporation Scientist Dr. Susan Dallabrida to Present Poster on ePRO for Multiple Myeloma at ESMO 2014 Congress

PR-Inside.com: 2014-09-04 16:27:01

Dr. Dallabrida recognized for driving innovation in patient-driven eData technologies that improve clinical research

Award-Winning PHT Corporation Scientist Dr. Susan Dallabrida to Present Poster on ePRO for Multiple Myeloma at ESMO 2014 Congress

For PHT Corporation
Brenda Nashawaty, 617-688-3253
brenda@nashawaty.com

PHT Corporation announced that Vice President of Clinical Science and Consulting Services Dr. Susan Dallabrida will present “Effective Use of Electronic Patient Reported Outcomes (ePRO) in Multiple Myeloma” at the ESMO 2014 Congress, 26-30 September in Madrid. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.

The ESMO 2014 Congress is sponsored by the European Society for Medical Oncology, the leading European professional organisation representing medical oncologists.

The poster abstract will also be published in the ESMO 2014 Congress Abstract Book, a supplement to the official ESMO journal Annals of Oncology.

The poster was developed by members of the PHT Clinical Science Team, with 100+ years of collective experience in ePROs and COAs:

  • Susan M. Dallabrida PhD, Vice President, Clinical Science & Consulting – Dr. Dallabrida has over 21 years of experience as a senior scientist, consultant and leader in clinical research and development, trial design and strategy, and product development. She has significant regulatory experience for biologics and small molecules.
  • Sarah Tressel Gary PhD, Senior Science Advisor – Dr. Gary has significant experience working with PRO development and validation studies, questionnaire design and working with developers of standardized instruments. She is experienced in migration studies including cognitive debriefing and usability testing in a number of therapeutic areas.

Learn more about the PHT Clinical Science Team: http://bit.ly/PHTCSC

Learn about the Effective Use, Analysis, and Best [..] in a new educational webinar, 10 September. Register here: http://www.phtcorp.com/About/News-Events/Upcoming-.

About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 17+ regulatory approvals. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.

Press Information


Published by
Hossam Abdel-Kader
+43 1 9582319
e-mail
www.pr-inside.com/



# 882 Words
Related Articles
 
More From Business
The perks of a Business Center
The concept of a Business Center is actually rather simple, yet it is very effective. Whether as a short term [..]
Tech vs Traditional Gifts: The Story Begins
A variety of gifting options can be found on GiftstoIndia24x7.com for different events and occasions. Such gifts are widely popular [..]
How to automatically cross-promote and schedule blog [..]
Social networks are leading sources for blog traffic. However, every social media follows its own rules, and it can be [..]
tML fibre-optic modules: LC ports with integrated [..]
Dortmund/Germany, 17 January 2017. As of now, tde trans data elektronik GmbH is offering tML fibre-optic modules with full dust [..]
What to gift your sister to make [..]
Return gifts are very important for your sister on Raksha bandhan as are rakhis for you on the same occasion. [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.